The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Designed as a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of EIDD-2801 on SARS-CoV-2 Virus Shedding in Newly Hospitalized Adults with polymerase chain reaction (PCR)-Confirmed COVID-19.
Epistemonikos ID: 836f076d9b28290d729f027ba5fc321ddced88ab
First added on: May 29, 2020